VOO

Entera Bio Heads Toward Phase 3 With EB613 in a 200 Million-Woman Osteoporosis Market (NASDAQ: ENTX)

Posted by on | Featured

WSW, NY, 23rd February 2026, FinanceWire … Read More

Tags: , , , ,

Nasus Pharma Is Targeting a Validated Market With a Potentially Superior Intranasal Delivery Approach

Posted by on | Featured

WSW, NY, 19th February 2026, FinanceWire … Read More

Tags: , , , , ,

Money Expo Mexico 2026 Starts with Historic Footfall in Latin America

Posted by on | Featured

Mexico, Mexico, 19th February 2026, FinanceWire … Read More

Tags: , , , , , , , , , , , , , , , , ,

Palatin Technologies’ Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline (NYSE: PTN)

Posted by on | Featured

WSW, NY, 18th February 2026, FinanceWire … Read More

Tags: , , , , ,

Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN)

Posted by on | Featured

WSW, NY, 17th February 2026, FinanceWire … Read More

Tags: , , , ,

Edgen Launches Autonomous AI Intelligence System for Real-Time Market Analysis

Posted by on | Featured

Hong Kong, Hong Kong, 12th February 2026, FinanceWire … Read More

Tags: , , , , , , , , , , ,

Entera Bio Attracts Former Pfizer Group President as It Enters a New Phase (NASDAQ: ENTX)

Posted by on | Featured

WSW, NY, 9th February 2026, FinanceWire … Read More

Tags: , , , , , , ,

Actelis Networks Appears to Be Gaining Momentum in 2026 as Infrastructure Orders Stack Up (NASDAQ: ASNS)

Posted by on | Featured

WSW, NY, 2nd February 2026, FinanceWire … Read More

Tags: , , , ,

MediWound’s EscharEx: A Late-Stage Asset Built for a Re-Normalized Wound Care Market (NASDAQ: MDWD)

Posted by on | Featured

WSW, NY, 29th January 2026, FinanceWire … Read More

Tags: , , , , , , ,

Purple Biotech’s “Capping” Technology Enables 300× Higher Dosing in Cancer Immunotherapy (NASDAQ: PPBT)

Posted by on | Featured

WSW, NY, 20th January 2026, FinanceWire … Read More

Tags: , , , , , ,